Stocks and Investing Stocks and Investing
Fri, April 26, 2024

Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $125 on, Apr 26th, 2024


Published on 2024-10-28 10:41:01 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $125 on, Apr 26th, 2024.

Andrew has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Wednesday, April 10th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com